Analysts/Institutional Investor Meet/Con. Call Updates

GPT Healthcare Limited Regd. Office: GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106, India CIN : L70101WB1989PLC047402 Phone : +91-33-4050-7000, Email : info@gptgroup.co.in , Visit us: www.gptgroup.co.in GPTHEALTH/CS/SE/2026-27 August 7, 2026 The Department of Corporate Services National Stock Exchange of India Limited BSE Limited, Exchange Plaza, Plot no. C/1, G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (E), Dalal Street Mumbai - 400 051 Mumbai – 400001 Scrip Symbol: GPTHEALTH Scrip Code: 544131 ISIN: INE486R01017 Dear Sir/Madam Subject: Transcript of the conference call on Un-Audited Financial Results for the 1st quarter ended on June 30,2026: In compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith transcript of conference call held on Tuesday, August 4, 2026 on Un-Audited Financial Results for the 1st quarter ended on June 30, 2026. Kindly take the aforesaid information on record and oblige. Thanking You, Yours sincerely, For GPT Healthcare Limited Ankur Sharma Company Secretary and Compliance Officer M. No A31833 Encl. As Above. “GPT Healthcare Limited Q1 FY27 Earnings Conference Call” August 04, 2026 MANAGEMENT: MR. ANURAG TANTIA – EXECUTIVE DIRECTOR – GPT HEALTHCARE LIMITED MRS. KRITI TANTIA – CHIEF FINANCIAL OFFICER – GPT HEALTHCARE LIMITED MR. ATUL TANTIA – GROUP CHIEF FINANCIAL OFFICER – GPT HEALTHCARE LIMITED MODERATOR: MS. SEJAL BHATTAR – MUFG INTIME Page 1 of 14 GPT Healthcare Limited August 04, 2026 Moderator: Ladies and gentlemen, good day, and welcome to GPT Healthcare Limited Q1 FY27 Earnings Conference Call. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing star, then zero on your touch-tone phone. Please note that this conference is being recorded. I now hand the conference over to Ms. Sejal Bhattar from MUFG Intime. Thank you, and over to you, ma'am. Sejal Bhattar: Thank you, Huda. Welcome to Q1 and FY27 earnings call of GPT Healthcare Limited. Today, on this call, we have with us Mr. Anurag Tantia, Executive Director; Mrs. Kriti Tantia, CFO; and Mr. Atul Tantia, Group CFO. Before we proceed the call, I would like to give a small disclaimer that this conference may contain certain forward-looking statements, which are based on beliefs, opinions and expectations of the company as on date. These statements are not guarantees of future performance and involve risks and uncertainties, which are difficult to predict. A detailed disclaimer has been given in the company's investor presentation, which is uploaded on the stock exchange. Now, I would like to hand over the conference to Mr. Anurag Tantia for the opening remarks. Thank you, and over to you, sir. Anurag Tantia: Good morning, everyone, and thank you for joining us today for GPT Healthcare Limited's Q1 FY27 earnings call. I hope all of you are keeping well. To begin with, let me share a few perspectives on the health care industry and the structural trends that continue to shape its long- term growth. India's health care sector is steadily shifting towards a model where the quality of care is becoming as critical as access. Rising incomes, greater health awareness and expanding insurance penetration are enabling more patients to seek timely treatment at organized hospitals that can deliver specialized clinical expertise and better clinical outcomes. Consequently, demand for tertiary and quaternary care services continues to grow faster than the overall health care market. At the same time, a substantial gap persists between the demand for quality health care and the available infrastructure. Although India's health care system has advanced meaningfully over the past decade, the supply of hospital beds and access to advanced medical facilities remain significantly below global benchmarks. This shortfall is particularly evident in Eastern and Central India, where large populations continue to be underserved despite increasing health care requirements. We are also observing a clear shift in patient expectations towards hospitals that provide comprehensive technology- driven care under one roof. Today's patients value not only experienced doctors, but also access to advanced diagnostics, robotic-assisted procedures, organ transplant programs and integrated critical care services. These capabilities are emerging as key differentiators for organized health care providers and Page 2 of 14 GPT Healthcare Limited August 04, 2026 are reshaping industry competition. In addition, the rapid adoption of digital health technologies and AI-enabled solutions are transforming the way health care is delivered and experienced. Against this evolving backdrop, our strategic focus remains consistent. We continue to invest in strengthening clinical excellence, expanding specialized offerings, improving patient outcomes and executing our expansion plans with discipline. We believe these priorities position GPT Healthcare well to capitalize on the long-term opportunities in the sector while delivering sustainable value to all stakeholders. Let me now take you through our operational highlights for the quarter. During the quarter, our total income increased by 18.2% and PAT increased by 66% compared to the same period last year. The network occupancy stood at 45.5%, while average revenue per occupied bed, or ARPOB, improved to INR42,350. Excluding the newly commissioned Raipur facility, occupancy across our mature hospitals maintained healthily at 58.07%, reflecting steady patient inflows and continued demand for specialized tertiary care. Approximately 90% of our revenues continue to be generated through cash and insurance patients, highlighting the strength of our payer mix and sustained demand for quality health care across our operating regions. Our performance during the quarter was supported by encouraging progress across each of the hospitals. Starting with ILS Hospital Salt Lake, our flagship tertiary care hospital continued to deliver strong operational performance. The hospital further strengthened its leadership in robotic-assisted surgeries with a cumulative number of robotic procedures now exceeding 800, reflecting increasing patient acceptance of advanced minimal invasive surgical techniques. During the quarter, occupancy stood at 62%, up from 60% on a Y-o-Y basis, while ARPOB improved to 45,300, supported by a favorable mix of higher contributing surgeries. The hospital also received the approval for conducting the previous prestigious DRNB course in medical gastroenterology. This adds to our bouquet of excellence in clinical and academic work. Moving to ILS Hospitals Dumdum. The hospital continued to build on the operational turnaround achieved over the past year and remained the highest occupied hospital within our network. The renal transplant program continues to be one of the most recognized in Eastern India, having successfully completed more than 700 renal transplants. During the year, the newly commissioned cardiothoracic and vascular surgery unit further strengthened our comprehensive cardiac care offerings, while advanced 3D imaging technology enhanced the hospital's interventional neurology capabilities. Dumdum also continued its participation in the BEMAKI clinical trial on acute kidney injury, reflecting our growing emphasis on clinical research and evidence-based health care. Occupancy for Dumdum stood at 65% compared to 60% of last year and ARPOB stood at 43,041. At ILS Hospital Agartala, we continue to strengthen our position as the leading corporate tertiary care hospital in Tripura. Our comprehensive cancer care centre equipped with PET scan and Linear Accelerator facilities has now completed more than 700 radiation procedure [Showing first 8,000 characters — download PDF for full document]